TNXP Tonix Pharma Total Asset Value of Company
This chart illustrates that the market value of Tonix Pharmaceuticals (TNXP) is 220.72. Tonix Pharmaceuticals (TNXP) complies with basic waste disposal standards, as it does not operate large-scale production facilities. The business relies on a comprehensive range of clinical trials in the fields of infections and the CNS, developing vaccines to combat global epidemics. Scientific research is focused on the cellular restoration of sleep and nerve functions in the treatment of chronic fatigue.
Analytical breakdowns and data insights for company Tonix Pharmaceuticals Inc. (TNXP)
Total assets define the aggregate resource base of Tonix Pharmaceuticals (TNXP), reflecting its solvency and the scale of its operational potential. This indicator is mathematically reconstructed via a reverse ROA calculation, capturing the dynamics of capital and liabilities. For Tonix Pharmaceuticals (TNXP), this serves as a metric for the efficiency of investments in the development of drugs for nervous system recovery. By analyzing the total asset trends of the enterprise, an investor can assess the financial stability of its innovative research.